stockrow
Friday 6 November 2026
Export USPH’s income statement to Excel — free account
U.S. Physical Therapy, Inc.
USPH Healthcare Medical Care Facilities
U.S. Physical Therapy, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $781.0 million, up 16.3% from fiscal 2024.
- Revenue
- +12.9%
- EPS
- −316.7%
- Free cash flow
- +32.2%
- Total debt
- +59.6%
Quarter to September 2026, against a year earlier
99.55
2.35
+2.42%
Follow USPH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
8.19% | 5.30% | 4.34% | 0.00% | |
Piotroski F-Score |
7 | 6 | 6 | — | |
| 3.34% | 2.12% | 1.70% | 0.00% | ||
ROIC |
9.12% | 7.83% | 7.48% | 0.00% | |
Return on Tangible Assets |
108.15% | 42.49% | 29.44% | 0.00% | |
Average Days of Receivables |
41.28 | 44.38 | 44.11 | 42.44 | |
Free Cash Flow per Share |
4.02 | 4.40 | 4.25 | 4.63 | |
Free Cash Flow |
60.99 | 66.68 | 64.07 | 69.10 | |
Capital Expenditures |
(14.07) | (16.86) | (18.98) | (19.74) | |
| Other line items | |||||
Cash ROIC |
9.17% | 9.64% | 9.29% | 9.73% | |
Accounts Receivable Turnover |
8.98 | 8.48 | 8.48 | 8.88 | |
Accounts Payable Turnover |
105.26 | 100.28 | 118.83 | 106.41 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
3.50 | 3.83 | 3.82 | 2.88 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | (0.26) | (0.26) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.87% | 8.96% | 8.97% | 8.74% | |
Share Based Compensation of Revenue |
1.06% | 1.11% | 1.21% | 1.26% | |
Interest Coverage |
9.16 | 7.97 | 7.11 | — | |
Operating CF/Net income |
1.90 | 3.25 | 4.02 | 0.00 | |
Depreciation/Fixed assets |
0.64 | 0.59 | 0.56 | 0.00 | |
Capex/Depreciation |
(0.62) | (0.73) | (0.83) | 0.00 | |
Revenue per Share |
51.47 | 52.45 | 53.90 | 56.11 | |
Operating CF per Share |
4.95 | 5.51 | 5.51 | 5.95 | |
Capex per Share |
(0.93) | (1.11) | (1.26) | (1.32) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026